• 제목/요약/키워드: Anti-HCV

검색결과 79건 처리시간 0.026초

Selective Ring-opening Fluorination of Epoxide: An Efficient Synthesis of 2'-C-Fluoro-2'-C-methyl Carbocyclic Nucleosides

  • Liu, Lian-Jin;Kim, Si-Wouk;Lee, Won-Jae;Hong, Joon-Hee
    • Bulletin of the Korean Chemical Society
    • /
    • 제30권12호
    • /
    • pp.2989-2992
    • /
    • 2009
  • An efficient synthetic route of novel 2′(${\alpha}$)-C-fluoro-2′(${\beta}$)-C-methyl carbocyclic nucleoside analogues is described. The key fluorinated intermediate 7 was prepared from the epoxide intermediate 5 via selective ring-opening of epoxide. Coupling of 7 with nucleosidic bases under the Mitsunobu reactions followed by deprotection afforded the target carbocyclic nucleoside analogues. The synthesized compounds were evaluated as inhibitors of the hepatitis C virus (HCV) in Huh-7 cell line in vitro.

일개 도시 일부 청년층(16-24세)의 B형, C형 간염에 관한 혈청역학적 연구 (A seroepidemiological Study of Hepatitis B and C Virus (HBV and HCV) Infections in the Young Population in parts of Busan, Korea)

  • 주영희;오진경;김동일;이덕희;김병권;김정일;정갑열;신해림
    • Journal of Preventive Medicine and Public Health
    • /
    • 제37권3호
    • /
    • pp.253-259
    • /
    • 2004
  • Objectives : To investigate the prevalence of hepatitis B and C virus infections and determine the associated risk factors among young adults in Busan, Korea, which is known to have a high incidence of liver cancer. Methods : The study population consisted of volunteer participants in a health survey during 2002, which included 1,350 students (515 males and 835 females) aged between 16 and 24 years, from three different schools in Busan. The participating students were asked to fill in a self-administered questionnaire which included lifestyle habits and risk factors of hepatitis. Sera obtained from the participants were studied for HBsAg, anti-HBs, and Anti-HCV by enzyme immunoassay (EIA) method and for liver function tests. Results : Among the study subjects (N=1,350), the seropositivities of HBsAg 7.9%(95% CI=7.8-8.0), 7.6%(95% CI=7.6-7.7) in male and 8.1%(95% CI=8.0-8.2) in female. And the seropositivity of Anti-HBs was 69.7%(95% CI=69.0-70.4), 70.5%(95% CI=69.8-71.2) in male and 69.2%(95% CI=68.5-69.9) in female. The seropositivity of Anti-HCV was 0.4%, 0.2% in male and 0.5% in female. The seropositivity for HBsAg in the subjects not having a hepatitis B vaccination history was twice(95% CI=1.0-4.4) that of those that did. Also, the seropositivity for HBsAg in subjects having experienced sexual intercourse was 1.7 times (95% CI=0.9-3.0) that of the subjects who had not. Conclusions : The present study confirmed the high prevalence of HBsAg seropositivity and sexual transmission of HBV among adolescents and young adults may occur. Further studies to evaluate the relationship between HBV vaccination and sexual transmission are required for the young population in Korea.

RIA, Recombinant Immunoblot Assay 및 Nested RT-PCR에 의한 C형 간염바이러스 검출 (Detection of Hepatitis C Virus by RIA, Recombinant Immunoblot Assay and Nested RT-PCR)

  • 김재수;김종완;이연태
    • 대한바이러스학회지
    • /
    • 제30권2호
    • /
    • pp.151-159
    • /
    • 2000
  • Hepatitis C virus (HCV) is one of the important human pathogen that can cause acute and chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Recently, the third generation radiation immuno assay (RIA) method has been developed as a very sensitive test to detect anti-HCV antibody. However, false positive is the problem with RIA test. To solve this the RIA results were compared to those of 5-antigen recombinant immunoblot assay (5-RIBA) and reverse transcription-polymerase chain reaction (RT-PCR). Among 12,767 serum samples tested from clinic visitors, total 275 (2.2%) samples were antibody positive by RIA. RIBA was performed with 148 RIA positives cases but among them was shown eighty five was antibody positive and sixty three (42.6%) was negative result. However, nested RT-PCR test was shown also carried out with 43 positive, 6 intermediates and 25 negatives of RIBA. As a result of the nested RT-PCR results, HCV antigen were detected in RIBA positive, 33.3% (2/6) RIBA intermediate and 12% (3/25). Clinical syndrome of all 148 patients as a with chronic active hepatitis (46.0%), cirrhosis (18.9%), hepatocellular carcinoma (8.1%) and others (27.0%) and they were positive in reaction by RIA test. But RIBA positive patients with 34.9% of chronic active hepatitis, 18.6% of cirrhosis, 4.6% of hepatocellular carcinoma and 41.9% of others were detected to be positive case by nested RT-PCR.

  • PDF

만성 C형 간염에 대한 ${\alpha}$-interferon 치료 후 ALT치의 변화 (Effect of ${\alpha}$-Interferon Treatment on Serum ALT Levels in Patients with Chronic Hepatitis C)

  • 이헌주
    • Journal of Yeungnam Medical Science
    • /
    • 제10권1호
    • /
    • pp.190-196
    • /
    • 1993
  • HCV에 감염된 환자중 반이상은 만성간염 환자로 이행되며 이중 20% 정동서는 간경변증 환자가 된다고 하며 그 외 간세포암 발생과의 관련성도 높다고 한다. 혈청으로 인한 각종 감염경로를 차단하는 것이 현재로서는 가장 확실한 C형 간염의 관리방법이긴 하나 약 반수정도의 환자는 산발형의 감염으로 뚜렷한 원인을 찾지 못하고 있다. 따라서 만성 C형 간염의 치료는 주요한 과제의 하나이며 최근 interferon 제제로 치료하여 ALT치의 정상화, 혈청 HCV RNA의 소실 및 간조직검사상의 상태개선이 가능하다는 국외의 희망적 보고들이 계속되고 있음은 다행한 일이며 이 보고내용에는 간편한 ALT치 검사가 치료경과 관찰 및 판정의 지표로 사용될 수 있음을 시사하고 있다. 저자는 1991년 5월부터 1992년 9월 사이에 영남대학교 의과대학 부속병원 내과에 내원하여 혈청 anti-HCV가 양성이며 임상적으로 최기간경변증 및 간조직검사상 만성간염 진단된 환자 16명에 대해 ${\alpha}$-interferon 300만 단위를 주 3회, 1-9(평균 4.0)개월동안 피하주사하고 그후 1-18(평균 7.0)개월후까지의 ALT치를 조사하였다. 치료중 대부분의 환자에서 ALT치의 감소가 있었으나 2명에서는 치료중 다시 상승되었다. 치료중단 후 6개월 이후에도 계속적으로 정상 ALT치를 보인 경우에는 9명중 4명(44.4%)였다. 대부분 환자에서 ALT치의 정상화는 치료시작후 1개월 전후에 관찰되었으며 치료중 ALT치의 파동이 있거나 늦게 정상화된 환자에서는 치료중단 후에도 ALT치의 파동이 있거나 정상 ALT치가 유지되지 않았다. 따라서 만성 C형간염 환자에서 ${\alpha}$-interferon의 치료는 간기능 개선에 도움이 되나 더 나은 성적을 위해서는 투여양과 기간을 치료에 따른 환자의 검사결과에 따라 변화시켜 사용하는 것이 도움이 될 것으로 여겨지고 이 치료에 전혀 반응이 없는 환자들에 대한 연구도 병행되어야 할 것으로 생각되며 또한 우리나라에서도 치료 후 장기간의 경과관찰, HCV RNA 검사 및 HCV genotyne에 관한 연구로서 만성 C형 간염에 대한 ${\alpha}$-interferon 치료효과를 더 정확히 평가해야 할 것으로 사료된다. 또한 최근에는 만성 C형간염의 ${\alpha}$-interferon 치료 후의 장기효과에 영향을 미칠 수 있는 여러조건들 즉 나이, 간경변의 유무, 치료전 NCV-RNA양 및 HCV와 genotype 등이 관심이 대상이 되기 시작하였으므로 향후 이점들에 대해서도 관찰이 시도되어야 할 것으로 사료된다.

  • PDF

Seroepidemiology of Hepatitis Viruses and Hepatitis B Genotypes of Female Marriage Immigrants in Korea

  • Kwon, Jae-Cheol;Chang, Hye Young;Kwon, Oh Young;Park, Ji Hoon;Oh, In Soo;Kim, Hyung Joon;Lee, Jun Hyung;Roh, Ha-Jung;Lee, Hyun Woong
    • Yonsei Medical Journal
    • /
    • 제59권9호
    • /
    • pp.1072-1078
    • /
    • 2018
  • Purpose: The Korean society has moved rapidly toward becoming a multicultural society. This study aimed to estimate the seroprevalence of hepatitis viruses and investigate hepatitis B virus (HBV) genotypic diversity in female marriage immigrants. Materials and Methods: Screening program was conducted at support centers for multicultural families in 21 administrative districts in Korea between July 2011 and January 2017. A total of 963 female marriage immigrants were included in this study. Blood samples were tested for hepatitis viral markers and HBV genotype. Results: Subjects' median age was 33 years (20-40 years), and they originated from nine countries including Vietnam (n=422, 43.8%), China (n=311, 32.3%), the Philippines (n=85, 8.8%), Cambodia (n=58, 6.0%), and Japan (n=39, 4.0%). About 30% (n=288) of subjects required hepatitis A vaccination. HBsAg positive rate was 5.4% (n=52). Positive HBsAg results were the highest in subjects from Southeast Asia (6.6%, n=38). Anti-HBs positive rate was 60.4% (n=582). About 34% (n=329) of subjects who were negative for anti-HBs and HBsAg required HBV vaccinations. Genotypes B and C were found in 54.6% (n=12) and 45.4% (n=10) of the 22 subjects with HBV, in whom genotypes were tested. Eight (0.8%) subjects were positive for anti-HCV. Positive anti-HCV results were the highest in subjects from Central Asia (7.9%, n=3). Conclusion: Testing for hepatitis viral marker (hepatitis A virus IgG and HBsAg/anti-HBs) is needed for female marriage immigrants. Especially, HBV genotype B is different from genotype C of Koreans. Therefore, interest and attention to vaccination programs for female marriage immigrants are necessary for both clinicians and public health institutes.

서울 경기지역 성인의 C형 간염 바이러스 항체 양성자 평균발생률; 후향적 코호트 연구 - 일개 병원의 종합검진 자료를 중심으로 - (Incidence Density of Antibody against Hepatitis C Virus in Seoul and Gyeonggi Area; A Retrospective Cohort Study - Based on Medical Screening Data from a General Hospital -)

  • 류승호;김동일;서병성;김원술;장유수;백승호;이수진;김용규;송재철
    • Journal of Preventive Medicine and Public Health
    • /
    • 제37권4호
    • /
    • pp.337-344
    • /
    • 2004
  • Objectives : This study was performed to determine the incidence density and the prevalence of sero-positive hepatitis C from 1999 to 2002 among adults aged 20 and over residing in Seoul and the Gyeonggi province. Method : The data for period was obtained from 114,635 adults, residing in Seoul or the Gyeonggi province, who had undertaken comprehensive health screening tests from Jan 1999 to Dec 2002 in a University hospital in Seoul. Among them, subjects with sero-negative status against hepatitis C were selected (21,408 in 1999, 28,830 in 2000) and then followed up until Dec 2002 to determine the incidence of hepatitis C during this period. The serum was tested with the immunoradiometric assay (IRMA) which uses third generation HCV antibody. Age adjusted rates were estimated by direct standardization using a reference population of 2000 aged from 20 to 80 years. Results : The prevalence of anti-HCV from 1999 to 2002 was 2.1 per 1000 persons(95% CI $1.8{\sim}2.4$). Male showed 1.7 per 1000 persons (95% CI $1.4{\sim}2.1$), while female showed 2.7 per 1000 persons(95% CI $2.2{\sim}3.2$). Age?sex adjusted rate showed 2.8 per 1000 persons (95% CI $2.64{\sim}2.96$), which is lower than the results of some previous study. The prevalence showed a significantly increasing pattern with age both in males and females (p<0.05). The incidence density of anti-HCV among the population aged 20 and over was 1.1 per 104 person-years at risk (95% CI $0.6{\sim}2.4$); 1.2 (95% CI $0.6{\sim}2.7$) for males and 0.8 (95% CI $0.6{\sim}4.2$) for females. Age adjusted incidence density was 2.91 per 104 person-years at risk (95% CI $2.43{\sim}3.38$) for those aged 20 and over. It showed an increasing pattern with age (p<0.05), especially for those age over 50 years. Conclusion : The study subjects for this study were supposedly healthier than the general population so the prevalence and incidence for the general population are thought to be higher than the results of the present study.

Prevalence of Aflatoxin Induced p53 Mutation at Codon 249 (R249s) in Hepatocellular Carcinoma Patients with and without Hepatitis B Surface Antigen (HBsAg)

  • Chittmittrapap, Salyavit;Chieochansin, Thaweesak;Chaiteerakij, Roongruedee;Treeprasertsuk, Sombat;Klaikaew, Naruemon;Tangkijvanich, Pisit;Komolmit, Piyawat;Poovorawan, Yong
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권12호
    • /
    • pp.7675-7679
    • /
    • 2013
  • Background: A missense mutation in exon 7 (R249S) of the p53 tumor suppressor gene is characteristic of aflatoxin B1 (AFB1) exposure. AFB1 is believed to have a synergistic effect on hepatitis virus B (HBV) carcinogenesis. However, results of studies comparing R249S prevalence among patients are conflicting. The aim of this study was to determine the prevalence of the R249S mutation in hepatocellular carcinoma (HCC) patients with or without positive HBsAg. Materials and Methods: Paraffin embedded liver tissues were obtained from 124 HCC patients who underwent liver resection and liver biopsy in King Chulalongkorn Memorial Hospital. Restriction fragment length polymorphism (RFLP) was utilized to detect the R249S mutation. Positive results were confirmed by direct sequencing. Results: Sixty four (52%) patients were positive for HBsAg and 18 (15%) were anti-HCV positive. 12 specimens tested positive by RFLP. Ten HCC patients (8.1%) were confirmed to be R249S positive by Sanger sequencing (AGG to AGT). Out of these 10, six were HBsAg positive, and out of the remaining 4, two were anti-HCV positive. The R249S prevalence among HCC patients with positive HBsAg was 9.4% compared to 6.7% for HBsAg negative samples. Patients with the R249S mutation were younger ($55{\pm}10$ vs $60{\pm}13$ year-old) and tended to have a more advanced Edmonson-Steiner grade of HCC, although differences did not reach statistical significance. Conclusions: Our study shows moderate prevalence of aflatoxin B1-related p53 mutation (R249S) in HCC with or without HBsAg. HBsAg positive status was not associated with R249S prevalence.

Cytomegalovirus Infection in Infantile Hepatitis

  • Na, So Young
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제15권2호
    • /
    • pp.91-99
    • /
    • 2012
  • Purpose: The aims of this study was to compare and evaluate the clinical characteristics, laboratory data, and prognosis for infants under age 1 year with CMV hepatitis and those with viral hepatitis of unknown etiology. Methods: A retrospective study was conducted of infants under age 1 year who were admitted with acute hepatitis. The exclusion criteria consisted of: autoimmune, genetic, metabolic, toxic, HAV, HBV, HCV, toxoplasma, rubella, herpes simplex, and Epstein-Barr virus. The 30 patients included were divided into two groups based on markers for CMV (IgM anti-CMV, CMV PCR in urine, CMV culture in urine). Results: The median age of patients (n=15) was 2.8 months. No other organ involvement was detected in any patient. Peak serum total bilirubin levels (n=4) ranged from 2.6 to 6.7 mg/dL. Peak serum ALT levels ranged from 51 to 1,581 IU/L. The duration of ALT elevation ranged from 1.5 weeks to 26 weeks (median 9 weeks). All had recovered in full without ganciclovir; there were no cases of hearing loss. The median age of controls (n=15) was 2.5 months. Peak serum total bilirubin levels (n=4) ranged from 1.6 to 9.1 mg/dL. Peak serum ALT levels ranged from 26 to 1,794 IU/L. No significant differences were observed between both groups regarding the peak serum ALT levels, peak serum total bilirubin levels, duration of hyperbilirubinemia and ALT elevation. Conclusion: Although it was not possible to differentiate congenital infection with perinatal infection in this study, the prognosis of patients with CMV hepatitis without other organ involvement was good without ganciclovir treatment.

Molecular Modeling of Small Molecules as BVDV RNA-Dependent RNA Polymerase Allosteric Inhibitors

  • Chai, Han-Ha;Lim, Dajeong;Chai, Hee-Yeoul;Jung, Eunkyoung
    • Bulletin of the Korean Chemical Society
    • /
    • 제34권3호
    • /
    • pp.837-850
    • /
    • 2013
  • Bovine viral diarrhea virus (BVDV), a major pathogen of cattle, is a well-characterized pestivirus which has been used as a good model virus for HCV. The RNA-dependent RNA polymerase (RdRp) plays a key role in the RNA replication process, thus it has been targeted for antivirus drugs. We employed two-dimensional quantitative structure-activity relationship (2D-QSAR) and molecular field analysis (MFA) to identify the molecular substructure requirements, and the particular characteristics resulted in increased inhibitory activity for the known series of compounds to act as effective BVDV inhibitors. The 2D-QSAR study provided the rationale concept for changes in the structure to have more potent analogs focused on the class of arylazoenamines, benzimidazoles, and acridine derivatives with an optimal subset of descriptors, which have significantly contributed to overall anti-BVDV activity. MFA represented the molecular patterns responsible for the actions of antiviral compound at their receptors. We conclude that the polarity and the polarizability of a molecule play a main role in the inhibitory activity of BVDV inhibitors in the QSAR modeling.

한방비만치료를 통한 비알코올성 지방간염 의증 환자의 간기능 개선 1례 보고 (Case of Oriental Obesity Treatment's Effect on Improvement of Nonalcoholic Steatohepatitis Patient's Liver Function)

  • 최빈혜;김동우;박경;김대준;변준석;허진일
    • 동의생리병리학회지
    • /
    • 제20권6호
    • /
    • pp.1785-1788
    • /
    • 2006
  • Nonalcoholic steatohepatitis(NASH) may progress to advanced liver disease. The diagnosis is made on liver biopsy when investigating a patient with raised transaminases and an otherwise negative biochemical and serological work-up. The subject was a obese male patient who had unexplained raised GOT, GPT. He had no alcoholic consumption and drug ingested. On serological examination, HBsAg and Anti-HCV test are negative. The subject was diagnosed as NASH, and was treated with oriental treatment for obesity. After 2months treatment the raised GOT, GPT decreased to normal range.